Top

Published in:

01-12-1998 | Article

Haptoglobin-related protein as a serum marker in malignant lymphoma

Authors: Ron Epelbaum, Channa Shalitin, Ruth Segal, Clari Valansi, Ida Arselan, David Faraggi, Michelle Leviov, Menahem Ben-Shahar, Nissim Haim

Published in: Pathology & Oncology Research | Issue 4/1998

Title: Haptoglobin-related protein as a serum marker in malignant lymphoma
Authors: Ron Epelbaum
Channa Shalitin
Ruth Segal
Clari Valansi
Ida Arselan
David Faraggi
Michelle Leviov
Menahem Ben-Shahar
Nissim Haim
Publication date: 01-12-1998
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 4/1998
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF02905217

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/1998

Immunohistopathological characterization of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) Xenograft

Aneurysmal bone cyst: Its pathogenesis based on angiographic, immunohistochemical and electron microscopic studies

The role of gastric mucosal dysplasia in the development of Gastric Carcinoma

Apoptosis and p53 expression in Human Gliomas

Diagnostics of multidrug resistance in cancer

Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer